Drug shortage: Dexmedetomidine Hydrochloride Injection (DEXMEDETOMIDINE, DEXMEDETOMIDINE HYDROCHLORIDE, PRECEDEX)
FDA lists 60 presentations as Current. Availability: Unavailable (10), Available (46). Reason: Demand increase for the drug; Delay in shipping of the drug. Companies: Eugia US LLC, Mylan Institutional, a Viatris Company, Pfizer Inc., Slayback Pharma, Fresenius Kabi USA, LLC….
- Published by source
- 2020-04-10
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Eugia US LLC
- Products
- Dexmedetomidine Hydrochloride Injection DEXMEDETOMIDINE DEXMEDETOMIDINE HYDROCHLORIDE PRECEDEX DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Check wholesalers for inventory
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-04-10
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #905 | new | 2026-10-22 | a9b866bd5e32…529a7a | 50653b08f187…05d8c3 |
Chain head: #1094 edf3be25ec2e…478842